Squamous cell carcinomas in 2 patients with diffuse scleroderma treated with mycophenolate mofetil.
Gulamhusein
Aliya
A
Pope
Janet E
JE
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced* / Q000276:immunology / Q000503:physiopathology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007049:Iatrogenic Disease / Q000517:prevention & control; D016867:Immunocompromised Host / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D018570:Risk Assessment; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D012867:Skin / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000276:immunology / Q000503:physiopathology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid